← All stocks

Cue Biopharma, Inc.

CUE Net buying
CIK 0001645460 #3995 in the set updated 17 Sep 2026
Bought (120 mo)
$5.98M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.68M
$0.00 on a plan · $3.73M straight out of an exercise
Sold at will
$1.95M
10 of 35 sales
Net
+$302.95K
+$4.03M against sales at will

By person

20 insiders · 79 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Fletcher Aaron G.L.
Director
$4.48M (6)
+$4.48M
1,113,867
$32.84M
+597.0%
Lin Shao-Lee
Chief Executive Officer
$1.61M (5) scheduled
−$1.61M
705,995
$20.81M
MARLETT CHRISTOPHER A
Director
$463.17K (10)
$1.43M (7)
−$963.51K
768,503
$22.66M
−23.8%
Suri Anish
PRESIDENT AND CSO
$19.78K (2)
$890.52K (6) scheduled
−$870.74K
135,638
$4.00M
+203.1%
Pienta Kenneth
Chief Medical Officer
$55.98K (2)
$509.66K (4) scheduled
−$453.68K
2,000
$58.96K
Kiener Peter A
Director
$392.28K (3) scheduled
−$392.28K
357
$10.52K
DIGIANDOMENICO ANTHONY
Director
$275.54K (5)
+$275.54K
57,000
$1.68M
Ray Sumita
Chief Legal Compliance Officer
$265.63K (3) scheduled
−$265.63K
118,545
$3.49M
+117.2%
Sandercock Colin
SVP, GENERAL COUNSEL
$132.66K (2)
$398.01K (3) scheduled
−$265.35K
17,125
$504.85K
+9,058%
PASSERI DANIEL R
CHIEF EXECUTIVE OFFICER
$187.89K (7)
+$187.89K
164,578
$4.85M
+311.4%
Meluzio Michael Vincent
VP, Prin. Accounting Officer
$169.32K (3) scheduled
−$169.32K
48,961
$1.44M
Gray Cameron
Director
$151.50K (2)
+$151.50K
687,049
$20.25M
+2.9%
Morich Frank
Director
$105.00K (1)
+$105.00K
28,000
$825.44K
Sarraf Pasha
Director
$99.75K (5)
+$99.75K
32,595
$960.90K
Millar Kerri-Ann
CHIEF FINANCIAL OFFICER
$8.48K (1)
$17.78K (1) scheduled
−$9.30K
14,311
$421.89K
Borie Dominique Christian
Chief Medical Officer
31,500
$928.62K
Ahlers James M
Chief Financial Officer
25,500
$751.74K
Garzone Pamela
Director
21,800
$642.66K
Camardo Daniel A.
Director
21,800
$642.66K
Meehan Viola Mong
Director
21,800
$642.66K

No percentages here. This company's share count has moved by a factor of 13.4 over the window, from 7,264,414 to 97,660,791 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Lin Shao-Lee
13 Aug 2026
Chief Executive Officer
Sell
10,460
$29.48
$308.36K
Lin Shao-Lee
13 Aug 2026
Chief Executive Officer
Sell
2,375
$28.11
$66.76K
Lin Shao-Lee
13 Aug 2026
Chief Executive Officer
Sell
5,423
$27.19
$147.45K
Meluzio Michael Vincent
13 Aug 2026
VP, Prin. Accounting Officer
Sold after exercise
3
$31.13
$93.39
Meluzio Michael Vincent
13 Aug 2026
VP, Prin. Accounting Officer
Sold after exercise
4,106
$30.35
$124.62K
Meluzio Michael Vincent
13 Aug 2026
VP, Prin. Accounting Officer
Sold after exercise
1,519
$29.37
$44.61K
Ray Sumita
13 Aug 2026
Chief Legal Compliance Officer
Sold after exercise
4
$31.13
$124.52
Ray Sumita
13 Aug 2026
Chief Legal Compliance Officer
Sold after exercise
6,442
$30.35
$195.51K
Ray Sumita
13 Aug 2026
Chief Legal Compliance Officer
Sold after exercise
2,383
$29.37
$69.99K
Lin Shao-Lee
12 Aug 2026
Chief Executive Officer
Sold after exercise
5,775
$27.75
$160.26K
Lin Shao-Lee
12 Aug 2026
Chief Executive Officer
Sold after exercise
34,225
$26.99
$923.73K
Sarraf Pasha
30 Dec 2025
Director
Buy
77,417
$0.30
$23.35K
Sarraf Pasha
30 Dec 2025
Director
Buy
78,116
$0.31
$24.33K
Sarraf Pasha
30 Dec 2025
Director
Buy
86,947
$0.32
$27.60K
Sarraf Pasha
30 Dec 2025
Director
Buy
77,148
$0.30
$23.17K
Sarraf Pasha
30 Dec 2025
Director
Buy
4,229
$0.31
$1.31K
PASSERI DANIEL R
16 Dec 2024
CHIEF EXECUTIVE OFFICER
Buy
30,000
$1.03
$30.90K
Suri Anish
25 Aug 2023
PRESIDENT AND CSO
Buy
4,000
$2.76
$11.04K
PASSERI DANIEL R
14 Aug 2023
CHIEF EXECUTIVE OFFICER
Buy
3,000
$2.86
$8.58K
Kiener Peter A
23 Mar 2023
Director
Sold after exercise
9,325
$3.28
$30.59K
Gray Cameron
14 Jun 2022
Director
Exercised, kept
61,111
$2.70
$165.00K
Morich Frank
27 May 2022
Director
Buy
28,000
$3.75
$105.00K
Fletcher Aaron G.L.
24 May 2022
Director
Buy indirect
55,000
$3.34
$183.70K
Fletcher Aaron G.L.
23 May 2022
Director
Buy indirect
150,000
$3.52
$528.00K
Fletcher Aaron G.L.
31 Mar 2022
Director
Buy indirect
735,000
$4.76
$3.50M
Kiener Peter A
16 Nov 2021
Director
Sold after exercise
1,361
$18.02
$24.53K
Suri Anish
15 Nov 2021
President and CSO
Sold after exercise
8,000
$18.05
$144.40K
Kiener Peter A
15 Nov 2021
Director
Sold after exercise
18,815
$17.92
$337.16K
Suri Anish
11 Nov 2021
President and CSO
Sold after exercise
20,000
$15.07
$301.35K
Millar Kerri-Ann
1 Oct 2021
CHIEF FINANCIAL OFFICER
Sold after exercise
1,251
$14.21
$17.78K
PASSERI DANIEL R
24 Sep 2021
CHIEF EXECUTIVE OFFICER
Buy
3,400
$14.72
$50.05K
Suri Anish
23 Sep 2021
PRESIDENT AND CSO
Sold after exercise
20,000
$15.23
$304.65K
Pienta Kenneth
16 Mar 2021
Chief Medical Officer
Sold after exercise
439
$15.09
$6.63K
Pienta Kenneth
15 Mar 2021
Chief Medical Officer
Sold after exercise
13,000
$15.10
$196.27K
Pienta Kenneth
17 Feb 2021
Chief Medical Officer
Sold after exercise
4,274
$15.06
$64.35K
Pienta Kenneth
16 Feb 2021
Chief Medical Officer
Sold after exercise
16,000
$15.15
$242.42K
Pienta Kenneth
20 Jan 2021
Chief Medical Officer
Buy
2,720
$15.07
$40.98K
Fletcher Aaron G.L.
24 Nov 2020
Director
Buy
6,548
$12.64
$82.78K
Gray Cameron
30 Sep 2020
Director
Buy
5,000
$15.30
$76.50K
Gray Cameron
29 Sep 2020
Director
Buy
5,000
$15.00
$75.00K
Suri Anish
5 Aug 2020
President and CSO
Sold after exercise
800
$20.01
$16.01K
Sandercock Colin
5 Aug 2020
SVP, General Counsel and Sec
Sold after exercise
13,274
$20.00
$265.48K
Suri Anish
4 Aug 2020
President and CSO
Sold after exercise
400
$20.14
$8.06K
Sandercock Colin
4 Aug 2020
SVP, General Counsel and Sec
Sold after exercise
201
$20.05
$4.03K
Suri Anish
3 Aug 2020
President and CSO
Sold after exercise
5,800
$20.01
$116.06K
Sandercock Colin
3 Aug 2020
SVP, General Counsel and Sec
Sold after exercise
6,425
$20.00
$128.50K
Fletcher Aaron G.L.
24 Jun 2020
Director
Buy
2,953
$25.24
$74.53K
Fletcher Aaron G.L.
24 Jun 2020
Director
Buy
4,547
$24.64
$112.04K
MARLETT CHRISTOPHER A
31 Dec 2019
Director
Sell
9,000
$15.71
$141.39K
MARLETT CHRISTOPHER A
31 Dec 2019
Director
Sell indirect
6,700
$15.77
$105.66K
MARLETT CHRISTOPHER A
27 Dec 2019
Director
Sell indirect
9,000
$17.24
$155.16K
MARLETT CHRISTOPHER A
26 Dec 2019
Director
Sell indirect
19,647
$17.53
$344.41K
MARLETT CHRISTOPHER A
23 Dec 2019
Director
Sell indirect
17,000
$16.82
$285.94K
MARLETT CHRISTOPHER A
19 Dec 2019
Director
Sell indirect
4,000
$17.00
$68.00K
MARLETT CHRISTOPHER A
17 Dec 2019
Director
Sell indirect
20,732
$15.73
$326.11K
PASSERI DANIEL R
21 Jun 2019
CEO and President
Buy
1,377
$7.26
$10.00K
Sandercock Colin
10 Jun 2019
SVP, General Counsel and Sec
Buy
14,938
$7.93
$118.46K
PASSERI DANIEL R
6 Jun 2019
CEO and President
Buy
3,000
$6.90
$20.70K
Sandercock Colin
6 Jun 2019
SVP, General Counsel and Sec
Buy
2,000
$7.10
$14.20K
MARLETT CHRISTOPHER A
31 Dec 2018
Director
Buy indirect
18,521
$4.64
$85.94K
DIGIANDOMENICO ANTHONY
28 Dec 2018
Director
Buy
7,000
$4.62
$32.34K
DIGIANDOMENICO ANTHONY
27 Dec 2018
Director
Buy
20,000
$4.77
$95.40K
MARLETT CHRISTOPHER A
26 Dec 2018
Director
Buy indirect
19,647
$4.29
$84.29K
DIGIANDOMENICO ANTHONY
24 Dec 2018
Director
Buy
10,000
$4.81
$48.10K
DIGIANDOMENICO ANTHONY
21 Dec 2018
Director
Buy
10,000
$4.49
$44.90K
MARLETT CHRISTOPHER A
21 Dec 2018
Director
Buy indirect
17,200
$4.53
$77.92K
Suri Anish
21 Dec 2018
Chief Scientific Officer
Buy
2,000
$4.37
$8.74K
MARLETT CHRISTOPHER A
20 Dec 2018
Director
Buy indirect
9,438
$4.74
$44.74K
MARLETT CHRISTOPHER A
19 Dec 2018
Director
Buy indirect
400
$5.00
$2.00K
MARLETT CHRISTOPHER A
18 Dec 2018
Director
Buy indirect
3,664
$5.20
$19.05K
DIGIANDOMENICO ANTHONY
17 Dec 2018
Director
Buy
10,000
$5.48
$54.80K
MARLETT CHRISTOPHER A
13 Dec 2018
Director
Buy indirect
10,000
$5.06
$50.60K
MARLETT CHRISTOPHER A
12 Dec 2018
Director
Buy indirect
3,189
$5.07
$16.17K
MARLETT CHRISTOPHER A
12 Dec 2018
Director
Buy
9,000
$5.09
$45.81K
MARLETT CHRISTOPHER A
11 Dec 2018
Director
Buy indirect
7,543
$4.86
$36.66K
Millar Kerri-Ann
29 Aug 2018
VP-Finance
Buy
1,000
$8.48
$8.48K
PASSERI DANIEL R
16 Aug 2018
CEO and President
Buy
6,000
$8.09
$48.51K
PASSERI DANIEL R
29 Jun 2018
CEO and President
Buy
1,600
$11.97
$19.15K
Pienta Kenneth
27 Dec 2017
Chief Medical Officer
Buy
2,000
$7.50
$15.00K

What was left out

Form 4 filings counted 211
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 25
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 3,484,440
Sales filed before the plan box existed 7
History held since 27 Dec 2017